Operating income |
3 Months Ended | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||
| Revenue [abstract] | |||||||||||||||||||||||||||||||
| Operating income | Operating income Operating income is composed as below:
Research tax credit (“CIR”) The Group carries out research and development projects. As such, it has benefited from a research tax credit for the three-month periods ended March 31, 2025 and 2026 for an amount of €970 thousand and €1,139 thousand, respectively. Depositary services fees This line item includes issuance, cancellation and depositary service fees collected from ADS holders by Citibank, who is acting as the Group's exclusive depositary for its publicly listed ADSs. As part of the depositary agreement between Citibank and the Group, the latter is entitled to receive a portion of the aforementioned fees collected by Citibank.
|